title: Restricting access to florbetapir: Medicare coverage criteria for diagnostics and drugs are inconsistent.
authors.affiliation: Tufts University, 75 Kneeland Street, Suite 1100, Boston, MA 02111, United States joshua.cohen@tufts.edu.
authors.forename: Joshua P
authors.initials: JP
authors.lastname: Cohen
authors.affiliation: Tufts University, 75 Kneeland Street, Suite 1100, Boston, MA 02111, United States.
authors.forename: Jinghui
authors.initials: J
authors.lastname: Dong
authors.affiliation: Harvard Medical School, Boston, MA 02215, United States.
authors.forename: Christine Y
authors.initials: CY
authors.lastname: Lu
authors.affiliation: Tufts University, 75 Kneeland Street, Suite 1100, Boston, MA 02111, United States.
authors.forename: Ranjana
authors.initials: R
authors.lastname: Chakravarthy
mesh_terms: D000544:Alzheimer Disease / Q000000981:diagnostic imaging* / Q000191:economics; D000814:Aniline Compounds / Q000191:economics; D003362:Cost-Benefit Analysis; D005026:Ethylene Glycols / Q000191:economics; D006801:Humans; D019458:Insurance Coverage; D006278:Medicare / Q000191:economics; D049268:Positron-Emission Tomography / Q000191:economics* / Q000379:methods; D019275:Radiopharmaceuticals / Q000191:economics; D015203:Reproducibility of Results; D014481:United States
chemical_list: D000814:Aniline Compounds; D005026:Ethylene Glycols; D019275:Radiopharmaceuticals; C545186:florbetapir